Anti-N-Methyl-D-Aspartate Receptor Encephalitis Following Fourth Dose of COVID-19 Vaccination: A Case Report.

IF 0.9 3区医学 Q4 NEUROSCIENCES

Neurology India Pub Date : 2024-09-01 Epub Date: 2024-10-19 DOI:10.4103/neurol-india.ni_1367_21

Mohammad Sayadnasiri, Fereydoun Layeghi

引用次数: 0

Abstract

Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis has been reported after severe acute respiratory disease coronavirus 2 (SARS-CoV-2) vaccination rarely. We report the second known case of anti-NMDAR encephalitis after receiving fourth dose of SARS-CoV-2 vaccine in a middle-aged male presenting with stroke-like symptoms, highlighting a rare potential neuroinflammatory complication of vaccination against SARS-CoV-2 that is currently being distributed worldwide. Despite the occurrence of such rare adverse events, the benefits of COVID-19 vaccination outweigh concerns over neurologic complications.

查看原文本刊更多论文

接种第四剂 COVID-19 疫苗后出现抗 N 甲基-D-天冬氨酸受体脑炎：病例报告。

接种严重急性呼吸系统疾病冠状病毒 2 型（SARS-CoV-2）疫苗后出现抗 N 甲基-d-天冬氨酸受体（NMDAR）脑炎的报道很少见。我们报告了第二例已知的接种第四剂 SARS-CoV-2 疫苗后出现抗 NMDAR脑炎的病例，患者是一名中年男性，表现为中风样症状。尽管发生了这种罕见的不良事件，但接种 COVID-19 疫苗的益处超过了对神经系统并发症的担忧。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neurology India 医学-神经科学

CiteScore

1.60

自引率

70.40%

发文量

434

审稿时长

2 months

期刊介绍： Neurology India (ISSN 0028-3886) is Bi-monthly publication of Neurological Society of India. Neurology India, the show window of the progress of Neurological Sciences in India, has successfully completed 50 years of publication in the year 2002. ‘Neurology India’, along with the Neurological Society of India, has grown stronger with the passing of every year. The full articles of the journal are now available on internet with more than 20000 visitors in a month and the journal is indexed in MEDLINE and Index Medicus, Current Contents, Neuroscience Citation Index and EMBASE in addition to 10 other indexing avenues. This specialty journal reaches to about 2000 neurologists, neurosurgeons, neuro-psychiatrists, and others working in the fields of neurology.